GELS
Gelteq Limited Ordinary Shares
NASDAQ: GELS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.66
+2.00% today
Updated 2026-05-01
Market cap
$6.91M
P/E ratio
—
P/S ratio
16.72x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
Gelteq Limited Ordinary Shares (GELS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | — | $-1.77M | $-1.07M | $-5.52M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $75931.00 | $148170.00 | $642234.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — |
| Free cash flow | — | — | — | $-1.85M | $-1.22M | $-6.16M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |